The resumption of the internationalization project of Jianfeng Pharmaceutical is progressing smoothly.
Release time:
2020-07-15
Since February 15, since the resumption of work was allowed, the peak pharmaceutical international project department seriously do a good job in the prevention and control of the new crown epidemic, project construction and other work have been carried out, the current project construction gradually resumed.
In order to resume construction as soon as possible, the International Project Department has organized and formulated the epidemic prevention and control work plan and emergency plan in strict accordance with the requirements of the group company and the pharmaceutical company, combined with the relevant documents of the Jinhua municipal government and the development zone. At the same time, in order to effectively prevent and control the epidemic, the project construction team, in strict accordance with the requirements of Jinhua Economic and Technological Development Zone, set up a grid team to earnestly implement the information investigation of rework personnel, carry out green health code inspection on all rework personnel, register the "Project Department Staff Health Registration Form" and sign the "Epidemic Prevention and Control Commitment". After the resumption of work, the project department will call the original Hubei construction personnel one by one and ask them to postpone their return. Effective isolation shall be carried out for rework personnel outside the province in accordance with the requirements of the development zone documents to ensure the supply of materials during the isolation period; Necessary epidemic prevention safeguard measures shall be provided for rework personnel who meet the standard of exemption from isolation. The construction unit equipped each rework personnel with protective masks, hand sanitizer and other protective equipment, measured their body temperature twice a day, reported their health status, disinfected and killed offices, canteens, dormitories, toilets and other areas every day, and cut off the source of infection. The implementation of these measures has safely and effectively ensured the orderly recovery of project construction.
At the beginning of the resumption of work, there were only a few dozen construction workers on the site, and with the phased results of epidemic prevention and control, the speed of construction workers returning to work gradually accelerated, and the project construction work began to get on the right track. As of March 19, the office building, quality inspection building, preparation workshop, power workshop and warehouse of Jianfeng Pharmaceutical International Project have all resumed normal operation according to the construction plan. The total number of reworking personnel in the project construction unit is 198, and the physical condition is normal. The civil construction of the peak pharmaceutical internationalization project basically returned to normal level. (Zhou Hengbin/Wen Zhang Genlong/Photograph)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page